Biospace Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 0.70 M
- Revenue Growth -0.49%
- Profit Growth -497.98%
- Ebitda -41.40%
- Net Worth -67.37%
- Total Assets -47.12%
About Biospace Technologies
Biospace Technologies Private Limited (BTPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 August 2010 and has a history of 14 years and six months. Its registered office is in Kottayam, Kerala, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.70 M.
Sebin Kurian, Rubin Jose, and Kavitha Rajagopal serve as directors at the Company.
Company Details
-
Location
Kottayam, Kerala, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U72200KL2010PTC026584
-
Company No.
026584
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Aug 2010
-
Date of AGM
30 Sep 2015
-
Date of Balance Sheet
31 Mar 2015
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Biospace Technologies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sebin Kurian
|
Managing Director | 18-Aug-2010 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Rubin Jose
|
Director | 18-Aug-2010 | Current |
|
Kavitha Rajagopal
|
Director | 18-Aug-2010 | Current |
Financial Performance of Biospace Technologies.
Biospace Technologies Private Limited, for the financial year ended 2015, experienced Minor drop in revenue, with a 0.49% decrease. The company also saw a substantial fall in profitability, with a 497.98% decrease in profit. The company's net worth observed a substantial decline by a decrease of 67.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biospace Technologies?
In 2015, Biospace Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.70 M
₹0
Charges Breakdown by Lending Institutions
- The South Indian Bank Limited : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2012 | The South Indian Bank Limited | ₹0.70 M | Open |
How Many Employees Work at Biospace Technologies?
Unlock and access historical data on people associated with Biospace Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biospace Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biospace Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.